Galenica AG operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Galenica AG with three other
drug stores in Europe:
Selcuk Ecza Deposu Ticaret ve Sanayi AS
sales of 17.81 billion Turkish Liras [US$2.56 billion]
of which 100%
was Medical and Hospital Equipment),
(1.72 billion Euros [US$2.03 billion]
of which 44%
was Consumer), and
based in POLAND
(8.28 billion Polish New Zlotys [US$2.21 billion]
of which 98%
was Pharmaceutical Wholesale).
Galenica AG reported sales of 3.30 billion Swiss Francs (US$3.60 billion)
December of 2019.
increase of 4.3%
versus 2018, when the company's sales were 3.17 billion Swiss Francs.
Sales of Health and Beauty saw an increase
6.0% in 2019, from
1.45 billion Swiss Francs to 1.54 billion Swiss Francs.